Cardiff, United Kingdom

Nigel Thomas


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Nigel Thomas

Introduction

Nigel Thomas is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. His work has implications for the treatment of various medical conditions, showcasing his dedication to advancing healthcare solutions.

Latest Patents

One of Nigel Thomas's key patents is titled "Sustained release cyclosporine-loaded microparticles." This patent describes a controlled release pharmaceutical formulation that includes cyclosporine-loaded microparticles made from a bioresorbable polymer, specifically poly(D,L-lactide). The microparticles have a mean diameter ranging from 20 µm to 40 µm. The formulation is particularly useful in treating uveitis and includes a process for production and injectable dosage forms, including those designed for intravitreal injection.

Career Highlights

Throughout his career, Nigel has worked with various companies, including Midatech Pharma (Wales) Limited and Midatech Pharma Limited. His experience in these organizations has allowed him to refine his skills and contribute to innovative pharmaceutical solutions.

Collaborations

Nigel has collaborated with several professionals in his field, including Paul Seaman and Katharine Bamsey. These partnerships have enhanced his research and development efforts, leading to impactful advancements in pharmaceutical formulations.

Conclusion

Nigel Thomas's work exemplifies the intersection of innovation and healthcare. His contributions, particularly in the area of controlled release formulations, highlight the importance of research in improving medical treatments. His dedication to advancing pharmaceutical science continues to inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…